J. Lipid Res. Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on June 1, 2005

Papers In Press, published online ahead of print March 16, 2005
J. Lipid Res., doi:10.1194/jlr.M400425-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M400425-JLR200v1
46/6/1163    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kong, W.
Right arrow Articles by Liu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kong, W.
Right arrow Articles by Liu, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on October 27, 2004
Revised on February 1, 2005
Accepted on February 28, 2005

In vivo activities of cytokine oncostatin M in regulation of plasma lipid levels

Weijia Kong, Parveen Ibidi, Fredric B. Kraemer, Jian-Dong Jiang, and Jingwen Liu

Research, VA Palo Alto Health Care System (154P), Palo Alto, CA 94304

Corresponding Author: Jingwen.Liu{at}med.va.gov

Our previous studies have demonstrated the activity of oncostatin M (OM) in stimulating the transcription of the human LDL receptor (LDLR) gene in HepG2 cells through a sterol-independent regulatory mechanism. The current studies were designed to determine whether this in vitro property of OM could be recapitulated in vivo to increase LDLR expression in cholesterol-loaded livers and consequently lower plasma levels of LDL-cholesterol and total cholesterol by using hypercholesterolemic hamsters as an experimental model. We show that administration of human recombinant OM for 7 days in hamsters fed a high fat diet significantly reduced plasma levels of total cholesterol, LDL-cholesterol, and triglyceride in dose- and time-dependent manners. This lipid lowering effect was associated with an elevated hepatic LDLR mRNA expression determined by quantitative real-time RT-PCR. Additionally, the hepatic fat storage and cholesterol content in the hypercholesterolemic animals were substantially reduced by OM treatment. As a consequence, the elevated aminotransferase levels in the high fat diet fed hamsters were normalized nearly to the baseline values. These results not only corroborate the in vitro finding of OM in the regulation of LDLR but also, for the first time, demonstrate that OM has a strong lipid lowering effect under in vivo conditions where levels of circulating LDL-c are high and liver LDLR transcription is repressed.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. Mozaffarian, A. W. Brewer, E. S. Trueblood, I. G. Luzina, N. W. Todd, S. P. Atamas, and H. A. Arnett
Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis
J. Immunol., November 15, 2008; 181(10): 7243 - 7253.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Y. Zhou, P. Abidi, A. Kim, W. Chen, T.-T. Huang, F. B. Kraemer, and J. Liu
Transcriptional Activation of Hepatic ACSL3 and ACSL5 by Oncostatin M Reduces Hypertriglyceridemia Through Enhanced {beta}-Oxidation
Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2198 - 2205.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.